Literature DB >> 19189425

Financing R&D for neglected diseases.

Paul L Herrling.   

Abstract

Mesh：

Year:  2009        PMID： 19189425     DOI： 10.1038/nrd2818

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  A breakthrough in R&D for neglected diseases: new ways to get the drugs we need.

Authors:  Mary Moran
Journal:  PLoS Med       Date:  2005-09-08       Impact factor: 11.069
  1 in total
  3 in total

1.  Drug Discovery in Academia- the third way?

Authors:  Julie Frearson; Paul Wyatt
Journal:  Expert Opin Drug Discov       Date:  2010-10-01       Impact factor: 6.098

2.  New antipoverty drugs, vaccines, and diagnostics: a research agenda for the US President's Global Health Initiative (GHI).

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

3.  R&D incentives for neglected diseases.

Authors:  Nicola Dimitri
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.